CCRP and adrenomedullin receptor populations in human cerebral arteries:: in vitro pharmacological and molecular investigations in different artery sizes

被引:32
作者
Sams, A
Knyihár-Csillik, E
Engberg, J
Szok, D
Tajti, J
Bodi, I
Edvinsson, L
Vécsei, L
Jansen-Olesen, I
机构
[1] Royal Danish Sch Pharm, Dept Pharmacol, DK-2100 Copenhagen O, Denmark
[2] Albert Szent Gyorgyi Med Univ, Dept Neurol, H-6701 Szeged, Hungary
[3] Albert Szent Gyorgyi Med Univ, Dept Pathol, H-6701 Szeged, Hungary
[4] Univ Lund Hosp, Dept Internal Med, S-22185 Lund, Sweden
关键词
lenticulostriate artery; human; RT-PCR; CGRP (calcitonin gene-related peptide); adrenomedullin; CRLR (calcitonin receptor-like receptor); RAMP (receptor activity-modifying protein);
D O I
10.1016/S0014-2999(00)00781-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to determine functional and molecular characteristics of receptors for calcitonin gene-related peptide (CGRP) and adrenomedullin in three different diameter groups of lenticulostriate arteries. Furthermore, the presence of perivascular neuronal sources of CGRP was evaluated in these arteries. In the functional studies, in vitro pharmacological experiments demonstrated that both CGRP and adrenomedullin induce alpha -CGRP-(8-37) sensitive vasodilation in artery segments of various diameters. The maximal amounts of vasodilation induced by CGRP and adrenomedullin were not different, whereas the potency of CGRP exceeded that of adrenomedullin by 2 orders of magnitude. Significant negative correlations between artery diameters and maximal responses were demonstrated for CGRP and adrenomedullin. In addition, the potency of both peptides tended to increase in decreasing artery diameter. In the molecular experiments, levels of mRNAs encoding CGRP receptors and receptor subunits were compared using reverse transcriptase polymerase chain reactions (RT-PCR). The larger the artery, the more mRNA encoding receptor activity-modifying proteins 1 and 2 (RAMP1 and RAMP2) was detected relative to the amount of mRNA encoding the calcitonin receptor-like receptor. By immunohistochemistry, perivascular CGRP containing nerve fibres were demonstrated in all the investigated artery sizes. In conclusion, both CGRP and adrenomedullin induced vasodilation via CGRP receptors in human lenticulostriate artery of various diameter. The artery responsiveness to the CGRP receptor agonists increased with smaller artery diameter, whereas the receptor-phenotype determining mRNA ratios tended to decrease. No evidence for CGRP and adrenomedullin receptor heterogeneity was present in lenticulostriate arteries of different diameters. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:183 / 193
页数:11
相关论文
共 46 条
[1]   Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage [J].
Ahmad, I ;
Imaizumi, S ;
Shimizu, H ;
Kaminuma, T ;
Ochiai, N ;
Tajima, M ;
Yoshimoto, T .
ACTA NEUROCHIRURGICA, 1996, 138 (10) :1230-1240
[2]   A cDNA encoding the calcitonin gene-related peptide type 1 receptor [J].
Aiyar, N ;
Rand, K ;
Elshourbagy, NA ;
Zeng, ZZ ;
Adamou, JE ;
Bergsma, DJ ;
Li, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) :11325-11329
[3]   Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord [J].
Arvieu, L ;
Mauborgne, A ;
Bourgoin, S ;
Oliver, C ;
Feltz, P ;
Hamon, M ;
Cesselin, F .
NEUROREPORT, 1996, 7 (12) :1973-1976
[4]   Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks [J].
Ashina, M ;
Bendtsen, L ;
Jensen, R ;
Schifter, S ;
Olesen, J .
PAIN, 2000, 86 (1-2) :133-138
[5]   A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1 [J].
Bühlmann, N ;
Leuthäuser, K ;
Muff, R ;
Fischer, JA ;
Born, W .
ENDOCRINOLOGY, 1999, 140 (06) :2883-2890
[6]   CGRP and adrenomedullin binding correlates with transcript levels for Calcitonin Receptor-Like Receptor (CRLR) and Receptor Activity Modifying Proteins (RAMPs) in rat tissues [J].
Chakravarty, P ;
Suthar, TP ;
Coppock, HA ;
Nicholl, CG ;
Bloom, SR ;
Legon, S ;
Smith, DM .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :189-195
[7]  
DENNIS T, 1989, J PHARMACOL EXP THER, V251, P718
[8]  
DENNIS T, 1990, J PHARMACOL EXP THER, V254, P123
[9]   Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist [J].
Doods, H ;
Hallermayer, G ;
Wu, DM ;
Entzeroth, M ;
Rudolf, K ;
Engel, W ;
Eberlein, W .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (03) :420-423
[10]   A potent and selective CGRP(2) agonist, [Cys(Et)(2,7)]hCGRP alpha: comparison in prototypical CGRP(1) and CGRP(2) in vitro bioassays [J].
Dumont, Y ;
Fournier, A ;
StPierre, S ;
Quirion, R .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (06) :671-676